[Perfusion changes in hemodilution. The effect of extensive isovolemic hemodilution with gelatin and hydroxyethylstarch solutions on cerebral blood flow velocity and cutaneous microcirculation in humans]

Influence of dextran-70 on systemic inflammatory response and myocardial ischaemia-reperfusion following cardiac operations

Introduction

Experimental studies have demonstrated that dextran-70 reduces the leukocyte–endothelium interaction, but clinical evidence is still lacking. Our objective was to justify the anti-inflammatory effect of dextran-70 following cardiac operations.

Methods

Forty patients undergoing coronary bypass surgery (n = 32) or aortic valve replacement (n = 8) were enrolled in this prospective, randomized, double-blind study. Two groups were formed. In group A (n = 20), dextran-70 infusion was administered at a dose of 7.5 ml/kg before the initiation of cardiopulmonary bypass and at a dose of 12.5 ml/kg after the cessation of cardiopulmonary bypass. Group B served as a control with identical amounts of gelatin infusion (n = 20). The plasma concentration of procalcitonin, C-reactive protein, IL 6, IL 6r, IL 8, IL 10, soluble endothelial leukocyte adhesion molecule-1, soluble intercellular adhesion molecule-1, cardiac troponin-I and various haemodynamic parameters were measured in the perioperative period. Multivariate methods were used for statistical analysis.

Results

In group A, lower peak (median) plasma levels of procalcitonin (0.2 versus 1.4, p < 0.001), IL 8 (5.6 versus 94.8, p < 0.001), IL 10 (47.2 versus 209.7, p = 0.001), endothelial leukocyte adhesion molecule-1 (88.5 versus 130.6, p = 0.033), intercellular adhesion molecule-1 (806.7 versus 1,375.7, P = 0.001) and troponin-I (0.22 versus 0.66, p = 0.018) were found. There was no significant difference in IL 6, IL-6r and C-reactive protein values between groups. Higher figures of the cardiac index (p = 0.010) along with reduced systemic vascular resistance (p = 0.005) were noted in group A.

Conclusion

Our investigation demonstrated that the use of dextran-70 reduces the systemic inflammatory response and cardiac troponin-I release following cardiac operation.

Trial registration number

ISRCTN38289094.

Effects of theophylline on human cerebral blood flow velocity during halothane and isoflurane anaesthesia

The acute influence of therapeutic doses of theophylline on cerebral blood flow velocities during general anaesthesia induced either by halothane or isoflurane has not been elucidated previously. The aim of this study, was therefore to investigate these effects during steady state anaesthetic conditions in anaesthetized patients using transcranial Doppler sonography. Thirty-four Patients were investigated. Anaesthesia was maintained either with 1 MAC (minimum alveolar concentration) halothane (n = 16) or 1 MAC isoflurane (n = 18); FiO2: 40%; end-expiratory pCO2: normocapnia. Theophylline administration was performed before surgery by infusing 6 mg kg-1 over a period of 7.5 min. Measurements were recorded prior to theophylline administration, and immediately after 2 mg kg-1 (2.5 min), 4 mg kg-1 (5 min) and 6 mg kg-1 (7.5 min), as well as 5, 10, 15, 20, 30 and 45 min after theophylline administration. Recorded variables included blood pressure, heart rate, arterial oxygen saturation, end-expiratory pCO2, body temperatures, middle cerebral artery blood flow velocity and pulsatility index. Theophylline administration was well tolerated by all study subjects. Heart rate, blood pressure, body temperatures, arterial oxygen saturation and end-expiratory pCO2 remained constant during the whole examination period. Following theophylline, mean blood flow velocity decreased by 25% in the halothane and by 30% in the isoflurane group (P < 0.05). By the end of the examination period, mean blood flow velocity had not yet recovered to the initial values whereby in both groups the mean blood flow velocity was 26% below the initial values. In the isoflurane group, the pulsatility index increased by about 20% (P < 0.05) and remained high until the end of the examination. In the halothane group, however, there were no changes in the pulsatility index. Our results show a remarkable, significant and simultaneous decrease in blood flow velocity in the middle cerebral artery associated with theophylline administration during halothane and isoflurane anaesthesia in man.

Cerebral blood flow velocity during isovolemic hemodilution and subsequent autologous blood retransfusion

PURPOSE

To quantify the influence of hematocrit on cerebral blood flow velocity (CBFV) in healthy volunteers undergoing acute isovolemic hemodilution (HD) with hydroxyethyl starch 10% (HES) and subsequent autologous whole blood retransfusion (RT).

METHODS

In 11 volunteers 20 ml x kg(-1) blood was withdrawn over 30 min and simultaneously replaced with HES 10%. Thirty min later, RT was started at a constant rate over 30 min. Recorded parameters included: CBFV pulsatility-index (PI) and resistance-index (RI) of the middle cerebral artery (MCA). Blood pressure (BP), heart rate (HR), hemoglobin (Hb), hematocrit (Hc) peripheral O2-saturation (SpO2), P(ET)CO2, arterial oxygen content (CaO2) and cerebral arterial O2-transport (C(E)-DO2= CaO2 x Vm-MCA) were monitored.

RESULTS

An average of 1570 total blood was withdrawn which resulted in a decrease in Hb from 14.5 mg x dl(-1) to 10.3 mg x dl(-1); Hc (and CaO2) decreased from 41.8% (19.8 ml x dl(-1)) to 29.6% (14.2 ml x dl(-1); P < 0.01). Vm-MCA increased from 61.2 cm x sec(-1) to 77.3 cm x sec(-1) (P < 0.01). Following RT, Vm-MCA decreased again, but remained higher than baseline (P < 0.01). PI decreased by 13% following RT (P < 0.05). There were no changes in RI, HR, BP SpO2 and P(ET)CO2. Regression lines could be fitted between Hc and Vm-MCA, Vm-MCA and CaO2, and between Hc and C(E)DO2.

CONCLUSIONS

Transcranial Doppler changes in blood flow velocities correlated with the simultaneously recorded systemic Hc and CaO2 values. We found a 2% increase in CBFV for each 1% decrease in Hc and CaO2.